The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19

The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19

During the current pandemic, the vast majority of COVID-19 patients experienced mild symptoms, but some had a potentially fatal aberrant hyperinflammatory immune reaction characterized by high levels of IL-6 and other cytokines. Modulation of this immune reaction has proven to be the only method of...

Full description

Bibliographic Details
Main Authors: Peter J. Richardson, Bruce W. S. Robinson, Daniel P. Smith, Justin Stebbing
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
baricitinib
antiviral
anti-cytokine
immune modulator
Online Access:https://www.mdpi.com/2076-393X/10/6/951

Similar Items

Similar Items